List of Tables
Table 1. Global Genome-Based Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Genome-Based Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Genome-Based Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Genome-Based Drug Sales (Kiloton) of Key Manufacturers (2020-2025)
Table 5. Global Genome-Based Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Genome-Based Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Genome-Based Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Genome-Based Drug Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Genome-Based Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genome-Based Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genome-Based Drug, Product Type & Application
Table 12. Global Key Manufacturers of Genome-Based Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genome-Based Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome-Based Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genome-Based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Genome-Based Drug Sales by Region (2020-2025) & (Kiloton)
Table 18. Global Genome-Based Drug Sales Market Share by Region (2020-2025)
Table 19. Global Genome-Based Drug Sales by Region (2026-2031) & (Kiloton)
Table 20. Global Genome-Based Drug Sales Market Share by Region (2026-2031)
Table 21. Global Genome-Based Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Genome-Based Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Genome-Based Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Genome-Based Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Genome-Based Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Genome-Based Drug Sales by Country (2020-2025) & (Kiloton)
Table 27. North America Genome-Based Drug Sales by Country (2026-2031) & (Kiloton)
Table 28. North America Genome-Based Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Genome-Based Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Genome-Based Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Genome-Based Drug Sales by Country (2020-2025) & (Kiloton)
Table 32. Europe Genome-Based Drug Sales by Country (2026-2031) & (Kiloton)
Table 33. Europe Genome-Based Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Genome-Based Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Genome-Based Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Genome-Based Drug Sales by Region (2020-2025) & (Kiloton)
Table 37. Asia Pacific Genome-Based Drug Sales by Region (2026-2031) & (Kiloton)
Table 38. Asia Pacific Genome-Based Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Genome-Based Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genome-Based Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Genome-Based Drug Sales by Country (2020-2025) & (Kiloton)
Table 42. Latin America Genome-Based Drug Sales by Country (2026-2031) & (Kiloton)
Table 43. Latin America Genome-Based Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genome-Based Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Genome-Based Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Genome-Based Drug Sales by Country (2020-2025) & (Kiloton)
Table 47. Middle East and Africa Genome-Based Drug Sales by Country (2026-2031) & (Kiloton)
Table 48. Middle East and Africa Genome-Based Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Genome-Based Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Genome-Based Drug Sales (Kiloton) by Type (2020-2025)
Table 51. Global Genome-Based Drug Sales (Kiloton) by Type (2026-2031)
Table 52. Global Genome-Based Drug Sales Market Share by Type (2020-2025)
Table 53. Global Genome-Based Drug Sales Market Share by Type (2026-2031)
Table 54. Global Genome-Based Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Genome-Based Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Genome-Based Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Genome-Based Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Genome-Based Drug Price (US$/Ton) by Type (2020-2025)
Table 59. Global Genome-Based Drug Price (US$/Ton) by Type (2026-2031)
Table 60. Global Genome-Based Drug Sales (Kiloton) by Application (2020-2025)
Table 61. Global Genome-Based Drug Sales (Kiloton) by Application (2026-2031)
Table 62. Global Genome-Based Drug Sales Market Share by Application (2020-2025)
Table 63. Global Genome-Based Drug Sales Market Share by Application (2026-2031)
Table 64. Global Genome-Based Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Genome-Based Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Genome-Based Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Genome-Based Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Genome-Based Drug Price (US$/Ton) by Application (2020-2025)
Table 69. Global Genome-Based Drug Price (US$/Ton) by Application (2026-2031)
Table 70. Sandoz International Company Information
Table 71. Sandoz International Description and Business Overview
Table 72. Sandoz International Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Sandoz International Genome-Based Drug Product
Table 74. Sandoz International Recent Developments/Updates
Table 75. Teva pharmaceutical industries Company Information
Table 76. Teva pharmaceutical industries Description and Business Overview
Table 77. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Teva pharmaceutical industries Genome-Based Drug Product
Table 79. Teva pharmaceutical industries Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Mylan Genome-Based Drug Product
Table 84. Mylan Recent Developments/Updates
Table 85. 3SBio Company Information
Table 86. 3SBio Description and Business Overview
Table 87. 3SBio Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. 3SBio Genome-Based Drug Product
Table 89. 3SBio Recent Developments/Updates
Table 90. Shanghai Fosun Pharmaceutical Company Information
Table 91. Shanghai Fosun Pharmaceutical Description and Business Overview
Table 92. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Shanghai Fosun Pharmaceutical Genome-Based Drug Product
Table 94. Shanghai Fosun Pharmaceutical Recent Developments/Updates
Table 95. Tonghua Dongbao Pharmaceutical Company Information
Table 96. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 97. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Tonghua Dongbao Pharmaceutical Genome-Based Drug Product
Table 99. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 100. Biocon Company Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Biocon Genome-Based Drug Product
Table 104. Biocon Recent Developments/Updates
Table 105. Reliance Life Sciences Company Information
Table 106. Reliance Life Sciences Description and Business Overview
Table 107. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Reliance Life Sciences Genome-Based Drug Product
Table 109. Reliance Life Sciences Recent Developments/Updates
Table 110. Probiomed Company Information
Table 111. Probiomed Description and Business Overview
Table 112. Probiomed Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Probiomed Genome-Based Drug Product
Table 114. Probiomed Recent Developments/Updates
Table 115. Biosidus Company Information
Table 116. Biosidus Description and Business Overview
Table 117. Biosidus Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Biosidus Genome-Based Drug Product
Table 119. Biosidus Recent Developments/Updates
Table 120. AMEGA Biotech Company Information
Table 121. AMEGA Biotech Description and Business Overview
Table 122. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. AMEGA Biotech Genome-Based Drug Product
Table 124. AMEGA Biotech Recent Developments/Updates
Table 125. Celltrion Company Information
Table 126. Celltrion Description and Business Overview
Table 127. Celltrion Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Celltrion Genome-Based Drug Product
Table 129. Celltrion Recent Developments/Updates
Table 130. LG Life Science Company Information
Table 131. LG Life Science Description and Business Overview
Table 132. LG Life Science Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. LG Life Science Genome-Based Drug Product
Table 134. LG Life Science Recent Developments/Updates
Table 135. Dong-A Pharmaceutical Company Information
Table 136. Dong-A Pharmaceutical Description and Business Overview
Table 137. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Dong-A Pharmaceutical Genome-Based Drug Product
Table 139. Dong-A Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Genome-Based Drug Distributors List
Table 143. Genome-Based Drug Customers List
Table 144. Genome-Based Drug Market Trends
Table 145. Genome-Based Drug Market Drivers
Table 146. Genome-Based Drug Market Challenges
Table 147. Genome-Based Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Genome-Based Drug
Figure 2. Global Genome-Based Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genome-Based Drug Market Share by Type: 2024 & 2031
Figure 4. Insulin Product Picture
Figure 5. Growth Hormone Product Picture
Figure 6. Monoclonal Antibody Product Picture
Figure 7. Other Product Picture
Figure 8. Global Genome-Based Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Genome-Based Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Pharmaceutical Factory
Figure 12. Other
Figure 13. Global Genome-Based Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Genome-Based Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Genome-Based Drug Sales (2020-2031) & (Kiloton)
Figure 16. Global Genome-Based Drug Average Price (US$/Ton) & (2020-2031)
Figure 17. Genome-Based Drug Report Years Considered
Figure 18. Genome-Based Drug Sales Share by Manufacturers in 2024
Figure 19. Global Genome-Based Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Genome-Based Drug Players: Market Share by Revenue in Genome-Based Drug in 2024
Figure 21. Genome-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Genome-Based Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Genome-Based Drug Sales Market Share by Country (2020-2031)
Figure 24. North America Genome-Based Drug Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Genome-Based Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe Genome-Based Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Genome-Based Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Genome-Based Drug Revenue Market Share by Region (2020-2031)
Figure 36. China Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Genome-Based Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Genome-Based Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Genome-Based Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Genome-Based Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Genome-Based Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Genome-Based Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Genome-Based Drug by Type (2020-2031)
Figure 58. Global Genome-Based Drug Price (US$/Ton) by Type (2020-2031)
Figure 59. Global Sales Market Share of Genome-Based Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Genome-Based Drug by Application (2020-2031)
Figure 61. Global Genome-Based Drug Price (US$/Ton) by Application (2020-2031)
Figure 62. Genome-Based Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
